Endoglin antibody
Quick Overview for Endoglin antibody (ABIN120662)
Target
See all Endoglin (ENG) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human
-
Purification
- Protein-A affinity chromatography
-
Purity
- > 95 % pure (by SDS-PAGE)
-
Immunogen
- Recombinant Vaccinia Virus containing human CD105 cDNA
-
Isotype
- IgG2a
-
-
-
-
Application Notes
-
Fow Cytometry. Immunoprecipitation. Western blotting (non-reducing conditions only).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.4
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
-
Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
Shelf Life: one year from despatch. -
Expiry Date
- 12 months
-
-
- Endoglin (ENG)
-
Alternative Name
- CD105 / Endoglin
-
Background
- CD105 (Endoglin) is a homodimeric transmembrane glycoprotein serving in presence of TGFbR-2 as a receptor for TGFb-1 and TGFb-3. CD105 is highly expressed on endothelial cells and promotes angiogenesis during wound healing, infarcts and in a wide range of tumours and its gene expression is stimulated by hypoxia. CD105 prevents apoptosis in hypoxic endothelial cells and also antagonises the inhibitory effects of TGFb-1 on vascular endothelial cell growth and migration. Normal cellular levels of CD105 are required for formation of new blood vessels.Synonyms: END, ENG, HHT1, ORW, ORW1
-
UniProt
- P17813
Target
-